论文部分内容阅读
日前,北京市药品监督管理局转发了国家药品监督管理局发布的2001年第2期药品质量公报,现将结果予以公布。 本期公报分四部分内容,第一部分是中国药品生物制品检定所按照2000年全国药品抽验计划进行同品种考核,共6个品种781个批号,其中有25个生产单位生产的4个品种、37个批号不合格;第二部分是各省级药品检验所按照抽验计划从生产单位(合医院制剂室)抽验的部分不合格药品,计8个单位生产(或配制)的7个
Recently, the Beijing Municipal Bureau of Drug Administration forwarded the State Drug Administration issued in 2001 No. 2 Pharmaceutical Quality Bulletin, the results will now be announced. This issue bulletin is divided into four parts. The first part is the examination of the same species by China National Institute for the Control of Pharmaceutical and Biological Products based on the 2000 National Drug Testing Plan. There are 781 batches of 6 varieties, of which 4 are produced by 25 production units and 37 Batch number unqualified; the second part is the provincial-level drug testing in accordance with the sampling plan from the production unit (hospital preparation room) part of the unqualified drug sampling, totaling 8 units (or preparation) 7